Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kymera Therapeutics, Inc.(KYMR) | 5,858,262 | 5,858,262 | 0 | $81.43M | $149.15M | 17.76% | +$67.72M |
| Disc Medicine, Inc.(IRON) | 2,745,335 | 2,555,172 | -190,163 | $128.98M | $147.59M | 17.58% | +$18.61M |
| Dyne Therapeutics, Inc.(DYN) | 9,885,449 | 9,885,449 | 0 | $88.57M | $131.48M | 15.66% | +$42.90M |
| Third Harmonic Bio, Inc. | 10,907,859 | 10,907,859 | 0 | $69.70M | $119.66M | 14.25% | +$49.96M |
| Day One Biopharmaceuticals, Inc. COM | 7,608,394 | 7,608,394 | 0 | $93.35M | $111.08M | 13.23% | +$17.73M |
| Korro Bio, Inc.(KRRO) | 0 | 1,119,292 | +1,119,292 | $0 | $53.65M | 6.39% | +$53.65M |
| Aerovate Therapeutics, Inc. | 2,039,249 | 2,039,249 | 0 | $27.67M | $46.15M | 5.50% | +$18.48M |
| Vigil Neuroscience, Inc. | 5,836,874 | 5,836,874 | 0 | $31.46M | $19.73M | 2.35% | -$11.73M |
| Replimune Group, Inc.(REPL) | 2,098,300 | 2,098,300 | 0 | $35.90M | $17.69M | 2.11% | -$18.21M |
| Generation Bio, Co. | 8,279,484 | 8,279,484 | 0 | $31.38M | $13.66M | 1.63% | -$17.72M |
| Ikena Oncology, Inc. | 5,018,178 | 5,018,178 | 0 | $21.73M | $9.89M | 1.18% | -$11.84M |
| Akero Therapeutics, Inc. | 359,251 | 359,251 | 0 | $18.17M | $8.39M | 1.00% | -$9.78M |
| AvroBio, Inc. | 4,541,381 | 4,541,381 | 0 | $6.99M | $6.18M | 0.74% | -$817.4K |
| Dianthus Therapeutics, Inc.(DNTH) | 236,979 | 236,979 | 0 | $3.24M | $2.46M | 0.29% | -$774.9K |
| Xilio Therapeutics, Inc.(XLO) | 2,759,344 | 2,759,344 | 0 | $5.82M | $1.52M | 0.18% | -$4.30M |
| Spero Therapeutics, Inc.(SPRO) | 1,013,438 | 1,013,438 | 0 | $1.23M | $1.49M | 0.18% | +$263.5K |